Tactile Systems Technology (TCMD) EPS (Weighted Average and Diluted) Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -6.66% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 7.81% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -1.10% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 62.43% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.44% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 61.98% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 27.51% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 6.01% |
| 10 | Tactile Systems Technology | 539.21 Mn | 449.02 Mn | 57.61 Mn | 3.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.85% |
| Dec 31, 2025 | 25.99% |
| Sep 30, 2025 | 74.05% |
| Jun 30, 2025 | 37.66% |
| Mar 31, 2025 | 44.97% |
| Dec 31, 2024 | 45.06% |
| Sep 30, 2024 | 47.90% |
| Jun 30, 2024 | 37.00% |
| Mar 31, 2024 | 9.14% |
| Dec 31, 2023 | -17.79% |
| Sep 30, 2023 | 98.60% |
| Jun 30, 2023 | 82.93% |
| Mar 31, 2023 | -8.74% |
| Dec 31, 2022 | 1.49% |
| Sep 30, 2022 | -42.88% |
| Jun 30, 2022 | -53.87% |
| Mar 31, 2022 | -127.34% |
| Dec 31, 2021 | -72.88% |
| Sep 30, 2021 | -57.26% |
| Jun 30, 2021 | -18.64% |
| Dec 31, 2020 | 73.80% |
| Sep 30, 2020 | 19.68% |
| Jun 30, 2020 | -77.58% |
| Mar 31, 2020 | 8.04% |
| Dec 31, 2019 | -6.60% |
| Sep 30, 2019 | 128.94% |
| Jun 30, 2019 | 51.83% |
| Mar 31, 2019 | 29.62% |
| Dec 31, 2018 | -25.48% |
| Sep 30, 2018 | 44.22% |
| Jun 30, 2018 | 45.55% |